Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells

[1]  Ying He,et al.  Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation , 2014, Molecular medicine reports.

[2]  M. Lim,et al.  Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells , 2014, Cancer Cell International.

[3]  Qutayba Hamid,et al.  Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation. , 2014, Toxicology and applied pharmacology.

[4]  M. Soleimani,et al.  Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases , 2014, Cell journal.

[5]  Wei Zhou,et al.  Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds. , 2014, Tissue engineering. Part A.

[6]  Zhenghui Wang,et al.  Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  F. Menaa,et al.  Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice. , 2014, Human gene therapy.

[8]  A. Jahanian-Najafabadi,et al.  Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress , 2014, Cell Stress and Chaperones.

[9]  Shikha Sharma,et al.  Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. , 2014, The international journal of biochemistry & cell biology.

[10]  H. Trivedi,et al.  In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1 , 2014, Cytotechnology.

[11]  J. Solano,et al.  Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia. , 2013, Hematology/oncology and stem cell therapy.

[12]  R. Zhao,et al.  Stepwise differentiation of human adipose-derived mesenchymal stem cells toward definitive endoderm and pancreatic progenitor cells by mimicking pancreatic development in vivo. , 2013, Stem cells and development.

[13]  E. Y. Kim,et al.  Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5 , 2013, Molecules and cells.

[14]  L. Ferroni,et al.  Potential for neural differentiation of mesenchymal stem cells. , 2012, Advances in biochemical engineering/biotechnology.

[15]  J. Burns,et al.  MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential. , 2013, Advances in biochemical engineering/biotechnology.

[16]  K. Martin,et al.  Tart cherry juice induces differential dose-dependent effects on apoptosis, but not cellular proliferation, in MCF-7 human breast cancer cells. , 2012, Journal of medicinal food.

[17]  G. Warnock,et al.  Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. , 2011, World journal of stem cells.

[18]  M. J. Mahon,et al.  Vectors bicistronically linking a gene of interest to the SV40 large T antigen in combination with the SV40 origin of replication enhance transient protein expression and luciferase reporter activity. , 2011, BioTechniques.

[19]  G. Warnock,et al.  Potential implications of mesenchymal stem cells in cancer therapy. , 2011, Cancer letters.

[20]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[21]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[22]  C. Hao,et al.  TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. , 2009, Reviews on recent clinical trials.

[23]  J. Hengstler,et al.  Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo , 2008, Gut.

[24]  J. Stagg Mesenchymal Stem Cells in Cancer , 2008, Stem Cell Reviews.

[25]  H. Rehman,et al.  Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest , 2007, Cancer biology & therapy.

[26]  T. Ochiya,et al.  Adipose tissue‐derived mesenchymal stem cells as a source of human hepatocytes , 2007, Hepatology.

[27]  C. Dani,et al.  Nucleofection Is a Valuable Transfection Method for Transient and Stable Transgene Expression in Adipose Tissue‐Derived Stem Cells , 2007, Stem cells.

[28]  M. Baccarani,et al.  Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow–Derived Mesenchymal Stem Cells , 2006, Stem cells.

[29]  R. Gay,et al.  Nucleofection: a new, highly efficient transfection method for primary human keratinocytes * , 2005, Experimental Dermatology.

[30]  Min-Jeong Seo,et al.  Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. , 2005, Biochemical and biophysical research communications.

[31]  G. Mills,et al.  Mesenchymal Stem Cells Promote Survival of Leukemic Cells Via Integrin-Linked Kinase (ILK)-Dependent Akt and STAT3 Activation: Implications for Leukemia Therapy. , 2004 .

[32]  H. Tsuda,et al.  Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.

[33]  Susana Castro-Obregon,et al.  New non-viral method for gene transfer into primary cells. , 2004, Methods.

[34]  F. Barry,et al.  Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.

[35]  X. Hao,et al.  Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis , 2003, Apoptosis.

[36]  A. Ashkenazi,et al.  Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. , 2003, Cytokine & growth factor reviews.

[37]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[38]  W. Wilkison,et al.  Neurogenic differentiation of murine and human adipose-derived stromal cells. , 2002, Biochemical and biophysical research communications.

[39]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.